NYSE - Delayed Quote • USD
McKesson Corporation (MCK)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 7:06 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 15 | 10 | 18 | 18 |
Avg. Estimate | 6.34 | 7.15 | 27.6 | 31.01 |
Low Estimate | 6.2 | 6.84 | 27.31 | 30.07 |
High Estimate | 6.68 | 7.29 | 27.93 | 31.6 |
Year Ago EPS | 7.19 | 7.27 | 25.94 | 27.6 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 12 | 7 | 15 | 15 |
Avg. Estimate | 79.35B | 80.84B | 311.94B | 337.77B |
Low Estimate | 77.7B | 78.17B | 310.3B | 332.67B |
High Estimate | 81.12B | 82.67B | 313.71B | 348.95B |
Year Ago Sales | 68.91B | -- | 276.71B | 311.94B |
Sales Growth (year/est) | 15.10% | -- | 12.70% | 8.30% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 7.17 | 5.87 | 6.15 | 7.05 |
EPS Actual | 7.19 | 7.27 | 6.23 | 7.74 |
Difference | 0.02 | 1.4 | 0.08 | 0.69 |
Surprise % | 0.30% | 23.90% | 1.30% | 9.80% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 6.34 | 7.15 | 27.6 | 31.01 |
7 Days Ago | 6.34 | 7.15 | 27.6 | 31.01 |
30 Days Ago | 6.35 | 7.13 | 27.61 | 31.01 |
60 Days Ago | 6.35 | 7.15 | 27.61 | 31 |
90 Days Ago | 6.77 | 7.25 | 27.31 | 30.79 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | 1 | 2 | 4 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | MCK | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -11.80% | -- | -- | 1.60% |
Next Qtr. | -1.70% | -- | -- | 10.50% |
Current Year | 6.40% | -- | -- | 5.20% |
Next Year | 12.40% | -- | -- | 13.30% |
Next 5 Years (per annum) | 10.61% | -- | -- | 11.22% |
Past 5 Years (per annum) | 18.33% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Maintains | Morgan Stanley: Overweight to Overweight | 4/15/2024 |
Maintains | Argus Research: Buy to Buy | 4/10/2024 |
Maintains | UBS: Buy to Buy | 3/6/2024 |
Initiated | Leerink Partners: Outperform | 2/26/2024 |
Maintains | Mizuho: Neutral to Neutral | 2/9/2024 |
Maintains | Citigroup: Buy to Buy | 2/8/2024 |
Related Tickers
COR Cencora, Inc.
239.13
+0.77%
CAH Cardinal Health, Inc.
108.19
+2.07%
OMI Owens & Minor, Inc.
24.79
+3.03%
HSIC Henry Schein, Inc.
70.86
+1.27%
ZYXI Zynex, Inc.
11.38
-0.61%
PDCO Patterson Companies, Inc.
26.02
+2.16%
ABC.VI Cencora, Inc.
222.65
0.00%
EDAP EDAP TMS S.A.
7.26
+1.82%
COSM Cosmos Health Inc.
0.4838
-20.17%
ENMI DH Enchantment, Inc.
0.0012
0.00%